• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by British American Tobacco Industries p.l.c. (Amendment)

    2/10/22 4:06:25 PM ET
    $BTI
    Medicinal Chemicals and Botanical Products
    Health Care
    Get the next $BTI alert in real time by email
    SC 13G/A 1 psl_bti13ga.htm SCHEDULE 13 G/A

     

     

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    SCHEDULE 13G

    Under the Securities Exchange Act of 1934
    (Amendment No. 1)*

    British American Tobacco PLC

    (Name of Issuer)

    ORDINARY SHARES

    (Title of Class of Securities)

    110448107

    (CUSIP Number)

    William Sullivan, 10 Market Street, #773 Camana Bay Grand Cayman, KY1-9006 CAYMAN ISLANDS, 345-640-3330

    (Name, Address and Telephone Number of Person
    Authorized to Receive Notices and Communications)

    December 31, 2021

    (Date of Event which Requires Filing of this Statement)

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
    ☐  Rule 13d-1(b)
    ☒  Rule 13d-1(c)
    ☐  Rule 13d-1(d)

    * The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

    The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     
     

     

     

     

    CUSIP No. 110448107 Page 2 of 7 13G/A    
             

     

             
    1.   NAMES OF REPORTING PERSONS
    I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

    PORTFOLIO SERVICES LTD
       
    2.   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
    (see instructions)
    (a)    
    ¨
    (b)    
    ¨
       
    3.   SEC USE ONLY
     
       
    4.   CITIZENSHIP OR PLACE OF ORGANIZATION
     
    CAYMAN ISLANDS
       

     

             
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH   5.   SOLE VOTING POWER
     
    0
      6.   SHARED VOTING POWER
     
    187,023,731
      7.   SOLE DISPOSITIVE POWER
     
    0
      8.   SHARED DISPOSITIVE POWER
     
    187,023,731

     

             
    9.   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

    187,023,731
       
    10.   CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
    (see instructions)    
    ¨
       
    11.   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

    8.2%
       
    12.   TYPE OF REPORTING PERSON (see instructions)

    CO
       
             

     

     
     

     

    CUSIP No. 110448107 Page 3 of 7 13G/A    
             

     

     

     

           
    1.   NAMES OF REPORTING PERSONS
    I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

    KENNETH B. DART
       
    2.   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
    (see instructions)
    (a)    
    ¨
    (b)    
    ¨
       
    3.   SEC USE ONLY
     
       
    4.   CITIZENSHIP OR PLACE OF ORGANIZATION
     
    CAYMAN ISLANDS
       

     

             
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH   5.   SOLE VOTING POWER
     
    0
      6.   SHARED VOTING POWER
     
    187,023,731
      7.   SOLE DISPOSITIVE POWER
     
    0
      8.   SHARED DISPOSITIVE POWER
     
    187,023,731

     

             
    9.   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

    187,023,731
       
    10.   CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
    (see instructions)    
    ¨
       
    11.   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

    8.2%
       
    12.   TYPE OF REPORTING PERSON (see instructions)

    IN
       
             

     

     
     

     

    CUSIP No. 110448107 Page 4 of 7 13G/A    
             

    Item 1.

      (a) Name of Issuer
    BRITISH AMERICAN TOBACCO PLC
         
      (b) Address of Issuer’s Principal Executive Offices
    GLOBE HOUSE, 4 TEMPLE PLACE, LONDON WC2R 2PG, UNITED KINGDOM
         

    Item 2.

      (a)

    Name of Person Filing
    1) PORTFOLIO SERVICES LTD.

    Portfolio Services Ltd. is a holding company that wholly owns several subsidiaries that hold the securities reported herein.

     

    2) KENNETH B. DART

    Mr. Dart is the beneficial owner of all of the outstanding shares of Portfolio Services Ltd.

         
      (b)

    Address of the Principal Office or, if none, residence
    1) 10 Market Street, #773

    Camana Bay

    Grand Cayman, KY1-9006 CAYMAN ISLANDS

     

    2) P.O. Box 31300

    Grand Cayman, KY1-1206 CAYMAN ISLANDS

         
      (c)

    Citizenship


    1) CAYMAN ISLANDS  

    2) BRITISH OVERSEAS TERRITORY CITIZEN CAYMAN ISLANDS

         
      (d) Title of Class of Securities
    ORDINARY SHARES
         
      (e) CUSIP Number
    110448107
         

     

     
     

     

    CUSIP No. 110448107 Page 5 of 7 13G/A    
             

    Item 3.  If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

      (a) ¨ Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).
           
      (b) ¨ Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).
           
      (c) ¨ Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).
           
      (d) ¨ Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).
           
      (e) ¨ An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);
           
      (f) ¨ An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);
           
      (g) ¨ A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G);
           
      (h) ¨ A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
           
      (i) ¨ A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
           
      (j) ¨ Group, in accordance with §240.13d-1(b)(1)(ii)(J).
           

    Item 4.  Ownership.

    Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.

    The percentage ownership noted in this Schedule 13G/A is based on 2,294,689,971 shares outstanding as reported Exhibit 1 of the Issuer’s 6K filed with the U.S. Securities and Exchange Commission on February 1, 2022.

    As of the date of this filing Portfolio Services Ltd., wholly owned subsidiaries of Portfolio Services, Ltd., and Mr. Dart beneficially own in aggregate the following:

             
      (a)   Amount beneficially owned:  187,023,731
             
      (b)   Percent of class:  8.2%
             
      (c)   Number of shares as to which the person has:  
             
          (i) Sole power to vote or to direct the vote  0
             
          (ii) Shared power to vote or to direct the vote  187,023,731
             
          (iii) Sole power to dispose or to direct the disposition of  0
             
          (iv) Shared power to dispose or to direct the disposition of  187,023,731
             
     
     

     

    CUSIP No. 110448107 Page 6 of 7 13G/A    
             

    Instruction. For computations regarding securities which represent a right to acquire an underlying security see §240.13d-3(d)(1).

    Item 5.  Ownership of Five Percent or Less of a Class.

    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following ☐.

    Instruction. Dissolution of a group requires a response to this item.

    Item 6.  Ownership of More than Five Percent on Behalf of Another Person.

    Not Applicable

    Item 7.  Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company.

    Not Applicable

    Item 8.  Identification and Classification of Members of the Group.

    Not Applicable

    Item 9.  Notice of Dissolution of Group.

    Not Applicable

    Item 10.  Certification.

    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.
     
     

     

     

    CUSIP No. 110448107 Page 7 of 7 13G/A    
             

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     

    Portfolio Services Ltd.

    02/10/2022

    Date

     

    /s/ Kenneth B. Dart

    Signature

     

    Kenneth B. Dart, Director

    Name/Title

     
    Kenneth B. Dart

    02/10/2022

    Date

     

    /s/ Kenneth B. Dart

    Signature

     

    Kenneth B. Dart, Director

    Name/Title

     

     

    Get the next $BTI alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $BTI

    DatePrice TargetRatingAnalyst
    4/30/2025Buy
    BofA Securities
    1/27/2025Neutral → Buy
    UBS
    10/3/2024$33.00Overweight → Underweight
    Morgan Stanley
    1/23/2024Neutral
    UBS
    11/1/2023$38.00Overweight
    Morgan Stanley
    9/25/2023Buy
    Citigroup
    9/1/2023Buy → Hold
    Argus
    3/13/2023Overweight → Neutral
    JP Morgan
    More analyst ratings

    $BTI
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Charlotte's Web Reports 2024 First Quarter Financial Results

      LOUISVILLE, Colo., May 8, 2024 /PRNewswire/ - (TSX:CWEB) (OTCQX:CWBHF), Charlotte's Web Holdings, Inc. ("Charlotte's Web" or the "Company"), the market leader in full-spectrum hemp extract wellness products, today reported financial results for the first quarter ended March 31, 2024. "The first quarter of 2024 started slowly in terms of sales volume. This is being addressed with solid progress in our 'True North' turnaround initiatives," said Bill Morachnick, Chief Executive Officer of Charlotte's Web. "For example, our legacy e-commerce platform limits our ability to be agile

      5/8/24 7:07:00 AM ET
      $BTI
      Medicinal Chemicals and Botanical Products
      Health Care
    • British American Tobacco p.l.c investors: Please contact the Portnoy Law Firm to recover your losses; March 25, 2024 deadline

      Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises British American Tobacco p.l.c (NYSE:BTI) investors that a lawsuit was filed on behalf of investors that purchased BTI securities between February 9, 2023 and December 6, 2023, inclusive (the "Class Period"). Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 844-767-8529 or email: [email protected], to discuss their legal rights, or click here to join the case via www.portnoylaw.com. The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors' options for pursuing cla

      1/24/24 6:21:08 PM ET
      $BTI
      Medicinal Chemicals and Botanical Products
      Health Care
    • Organigram Announces C$124.6 Million Investment from BAT and Creation of "Jupiter" Strategic Investment Pool

      Organigram and BAT deepen partnership through C$124.6 million investment with 38.7 million shares to be issued over three tranches Organigram to use C$83.1 million of the investment to create "Jupiter," a strategic investment pool designed to expand Organigram's geographic footprint and capitalize on emerging growth opportunities C$41.5 million of the investment will be used for general corporate purposes Investment enhances strategic Product Development Collaboration between BAT and Organigram, which focuses on cutting-edge R&D and product innovation BAT to increase voting Common Share ownership position to 30% and overall equity interest to 45% (including non-voting Class A P

      11/6/23 6:00:00 AM ET
      $BTI
      $OGI
      Medicinal Chemicals and Botanical Products
      Health Care
      Biotechnology: Pharmaceutical Preparations

    $BTI
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • BofA Securities resumed coverage on British American Tobacco

      BofA Securities resumed coverage of British American Tobacco with a rating of Buy

      4/30/25 9:01:21 AM ET
      $BTI
      Medicinal Chemicals and Botanical Products
      Health Care
    • British American Tobacco upgraded by UBS

      UBS upgraded British American Tobacco from Neutral to Buy

      1/27/25 7:35:54 AM ET
      $BTI
      Medicinal Chemicals and Botanical Products
      Health Care
    • British American Tobacco downgraded by Morgan Stanley with a new price target

      Morgan Stanley downgraded British American Tobacco from Overweight to Underweight and set a new price target of $33.00

      10/3/24 7:24:54 AM ET
      $BTI
      Medicinal Chemicals and Botanical Products
      Health Care

    $BTI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by British American Tobacco Industries p.l.c. (Amendment)

      SC 13G/A - British American Tobacco p.l.c. (0001303523) (Subject)

      2/9/24 6:03:23 PM ET
      $BTI
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form SC 13G/A filed by British American Tobacco Industries p.l.c. (Amendment)

      SC 13G/A - British American Tobacco p.l.c. (0001303523) (Subject)

      2/9/24 5:46:32 PM ET
      $BTI
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form SC 13G/A filed by British American Tobacco Industries p.l.c. (Amendment)

      SC 13G/A - British American Tobacco p.l.c. (0001303523) (Subject)

      1/26/24 4:56:06 PM ET
      $BTI
      Medicinal Chemicals and Botanical Products
      Health Care

    $BTI
    SEC Filings

    See more
    • SEC Form 6-K filed by British American Tobacco Industries p.l.c.

      6-K - British American Tobacco p.l.c. (0001303523) (Filer)

      5/9/25 11:07:44 AM ET
      $BTI
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form 6-K filed by British American Tobacco Industries p.l.c.

      6-K - British American Tobacco p.l.c. (0001303523) (Filer)

      5/6/25 12:33:01 PM ET
      $BTI
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form 6-K filed by British American Tobacco Industries p.l.c.

      6-K - British American Tobacco p.l.c. (0001303523) (Filer)

      5/1/25 7:49:52 AM ET
      $BTI
      Medicinal Chemicals and Botanical Products
      Health Care

    $BTI
    Leadership Updates

    Live Leadership Updates

    See more
    • British American Tobacco p.l.c investors: Please contact the Portnoy Law Firm to recover your losses; March 25, 2024 deadline

      Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises British American Tobacco p.l.c (NYSE:BTI) investors that a lawsuit was filed on behalf of investors that purchased BTI securities between February 9, 2023 and December 6, 2023, inclusive (the "Class Period"). Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 844-767-8529 or email: [email protected], to discuss their legal rights, or click here to join the case via www.portnoylaw.com. The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors' options for pursuing cla

      1/24/24 6:21:08 PM ET
      $BTI
      Medicinal Chemicals and Botanical Products
      Health Care
    • Charlotte's Web Announces Appointment of Bill Morachnick as Chief Executive Officer

      Provides Update on Majority Voting Policy Process LOUISVILLE, Colo., Sept. 13, 2023 /PRNewswire/ - (TSX:CWEB) (OTCQX:CWBHF) Charlotte's Web Holdings, Inc. ("Charlotte's Web" or the "Company") is pleased to announce the appointment of William (Bill) Morachnick who has joined the Company as its Chief Executive Officer. Mr. Morachnick has also been appointed to the Company's Board of Directors as a non-independent director. He replaces CEO Jacques Tortoroli who has elected to resign from his roles at Charlotte's Web.  CWEB) (OTCQX:CWBHF):. The World's Most Trusted Hemp Extract and Official CBD of Major League Baseball (MLB). (C

      9/13/23 7:07:00 AM ET
      $BTI
      Medicinal Chemicals and Botanical Products
      Health Care
    • GREENBUTTS APPPOINTS FORMER BIG TOBACCO EXECUTIVE AS CHIEF STRATEGY OFFICER

      SAN DIEGO, Calif., June 22, 2022 /PRNewswire/ - Greenbutts, LLC (the "Company" or "Greenbutts") is pleased to announce the appointment of Luis Sanches as the Company's Chief Strategy Officer effective immediately. Luis is a Senior Corporate Executive with more than 30 years of international, cross functional and cross-cultural experience responsible for managing business teams, supporting growth, and leading transformations across multiple geographies such as Australasia, North and South America, and Europe. He was previously the Senior Vice President of R&D for Reynolds Ameri

      6/22/22 2:34:00 PM ET
      $BTI
      Medicinal Chemicals and Botanical Products
      Health Care

    $BTI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 3 filed by new insider Bt De Investments Inc.

      3 - British American Tobacco p.l.c. (0001303523) (Reporting)

      11/23/22 4:29:54 PM ET
      $BTI
      Medicinal Chemicals and Botanical Products
      Health Care

    $BTI
    Financials

    Live finance-specific insights

    See more
    • Charlotte's Web Reports 2024 First Quarter Financial Results

      LOUISVILLE, Colo., May 8, 2024 /PRNewswire/ - (TSX:CWEB) (OTCQX:CWBHF), Charlotte's Web Holdings, Inc. ("Charlotte's Web" or the "Company"), the market leader in full-spectrum hemp extract wellness products, today reported financial results for the first quarter ended March 31, 2024. "The first quarter of 2024 started slowly in terms of sales volume. This is being addressed with solid progress in our 'True North' turnaround initiatives," said Bill Morachnick, Chief Executive Officer of Charlotte's Web. "For example, our legacy e-commerce platform limits our ability to be agile

      5/8/24 7:07:00 AM ET
      $BTI
      Medicinal Chemicals and Botanical Products
      Health Care
    • Charlotte's Web Reports 2023 Second Quarter Financial Results

      Encouraging CBD regulatory progress in CongressNet revenue of $16.0M vs. $18.9M YoYCash increased to $61.7M LOUISVILLE, Colo., Aug. 10, 2023 /PRNewswire/ - (TSX:CWEB) (OTCQX:CWBHF), Charlotte's Web Holdings, Inc. ("Charlotte's Web" or the "Company"), the market leader in full spectrum hemp extract wellness products, today reported financial results for the second quarter ended June 30, 2023.  Regulatory Update During the second quarter, the U.S. Food and Drug Administration ("FDA") committed to "work at speed" with Congress to resolve a regulatory pathway for hemp-derived CBD.

      8/10/23 7:33:00 AM ET
      $BTI
      Medicinal Chemicals and Botanical Products
      Health Care
    • Charlotte's Web Reports 2023 First Quarter Financial Results

      Net cash of $61MNet revenue of $17M decreased 12.1% YoY14% YoY reduction in operating expenses LOUISVILLE, Colo., May 12, 2023 /PRNewswire/ - (TSX:CWEB) (OTCQX:CWBHF), Charlotte's Web Holdings, Inc. ("Charlotte's Web" or the "Company"), the market leader in full spectrum hemp extract wellness products, today reported financial results for the first quarter ended March 31, 2023. "In the first quarter, we maintained prudent cost controls to balance softness in the CBD category due to the unregulated environment. We successfully reduced operating expenses by 14% on a year-over-ye

      5/12/23 7:05:00 AM ET
      $BTI
      Medicinal Chemicals and Botanical Products
      Health Care